Craig Collard

Insider Reports History

Entity
Individual
Location
C/O Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, NC
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig Collard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Employee Stock Option (Right to Buy) 1.32M $2.36M $1.78 Jan 19, 2024 Direct
TerrAscend Corp. Director Common Shares 717K $1.44M $2.01 Jun 17, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Common Stock 290K $767K $2.64 Oct 19, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Restricted Stock Units 179K $474K $2.64 Oct 19, 2024 Direct
TerrAscend Corp. Director Share Option (Right to Buy) 150K Jun 17, 2024 Direct
OPIANT PHARMACEUTICALS, INC. Director Common Stock 0 $20.00 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Director Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct
Sierra Oncology, Inc. Director Common Stock 0 $55.00 Jul 1, 2022 Direct
Sierra Oncology, Inc. Director Stock Option (right to buy) 0 Jul 1, 2022 Direct

Insider Reports Filed by Craig Collard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 19, 2024 2 $0 4 Oct 21, 2024 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 19, 2024 2 $0 4 Jul 22, 2024 Chief Executive Officer, Director
TSNDF TerrAscend Corp. Jun 17, 2024 3 $0 4 Jun 20, 2024 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 19, 2024 2 $0 4 Apr 19, 2024 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 3, 2024 2 $0 4 Apr 5, 2024 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 19, 2024 2 $0 4 Jan 19, 2024 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Nov 16, 2023 1 $138K 4 Nov 17, 2023 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Aug 22, 2023 1 -$1.14K 4 Aug 24, 2023 Chief Executive Officer, Director
TSNDF TerrAscend Corp. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ May 22, 2023 1 -$1K 4 May 24, 2023 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 3, 2023 3 $0 4 Apr 5, 2023 Chief Executive Officer, Director
OPNT OPIANT PHARMACEUTICALS, INC. Mar 2, 2023 6 -$1.12M 4 Mar 3, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Feb 22, 2023 0 $0 3 Mar 2, 2023 Director
TSNDF TerrAscend Corp. Sep 23, 2022 1 $0 4 Sep 27, 2022 Director
TSNDF TerrAscend Corp. Sep 22, 2022 1 $0 4 Sep 26, 2022 Director
SRRA Sierra Oncology, Inc. Jul 1, 2022 3 -$743K 4 Jul 1, 2022 Director
TSNDF TerrAscend Corp. Jun 27, 2022 2 $0 4 Jun 29, 2022 Director
OPNT OPIANT PHARMACEUTICALS, INC. Jun 14, 2022 1 $0 4 Jun 14, 2022 Director
OPNT OPIANT PHARMACEUTICALS, INC. Jun 10, 2022 2 $63.3K 4 Jun 13, 2022 Director
OPNT OPIANT PHARMACEUTICALS, INC. May 16, 2022 1 $368K 4 May 17, 2022 Director
OPNT OPIANT PHARMACEUTICALS, INC. May 13, 2022 1 $38.7K 4 May 16, 2022 Director
TSNDF TerrAscend Corp. Jan 6, 2022 2 $134K 4 Jan 10, 2022 Director
TSNDF TerrAscend Corp. Jan 1, 2022 0 $0 3 Jan 3, 2022 Director
SRRA Sierra Oncology, Inc. Nov 23, 2021 2 $311K 4 Nov 24, 2021 Director
OPNT OPIANT PHARMACEUTICALS, INC. Sep 13, 2021 3 $67.1K 4 Sep 15, 2021 Director
OPNT OPIANT PHARMACEUTICALS, INC. Sep 10, 2021 1 $174K 4 Sep 13, 2021 Director
OPNT OPIANT PHARMACEUTICALS, INC. Jun 15, 2021 2 $0 4 Jun 16, 2021 Director
SRRA Sierra Oncology, Inc. Jun 8, 2021 1 $0 4 Jun 9, 2021 Director